ArticleBMC cancer2024

Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era.

Cheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.